Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78M | Hold |
53,954
| – | – | 0.8% | 27 |
|
|
2025
Q1 | $5.97M | Hold |
53,954
| – | – | 1.23% | 24 |
|
|
2024
Q4 | $7.36M | Sell |
53,954
-193,089
| -78% | -$26.4M | 0.89% | 35 |
|
|
2024
Q3 | $28.5M | Buy |
247,043
+187,618
| +316% | +$21.6M | 3.95% | 7 |
|
|
2024
Q2 | $8.18M | Hold |
59,425
| – | – | 1.33% | 26 |
|
|
2024
Q1 | $8.2M | Hold |
59,425
| – | – | 1.26% | 25 |
|
|
2023
Q4 | $7.83M | Hold |
59,425
| – | – | 1.78% | 20 |
|
|
2023
Q3 | $6.69M | Hold |
59,425
| – | – | 2.11% | 17 |
|
|
2023
Q2 | $5.6M | Hold |
59,425
| – | – | 1.63% | 21 |
|
|
2023
Q1 | $6.01M | Hold |
59,425
| – | – | 2.13% | 20 |
|
|
2022
Q4 | $7.1M | Hold |
59,425
| – | – | 3.08% | 17 |
|
|
2022
Q3 | $6.31M | Buy |
+59,425
| New | +$6.31M | 2.98% | 18 |
|